Foxq1 Promotes Alveolar Epithelial Cell Death through Tle1-mediated Inhibition of the NFκB Signaling Pathway

Acute lung injury is a common respiratory disease characterized by diffuse alveolar injury and interstitial edema, as well as a hyperinflammatory response, lung cell damage and oxidative stress. Foxq1, a member of the FOX family of transcription factors, is expressed in various tissues, such as the lungs, liver, and kidneys, and contributes to various biological processes, such as stress, metabolism, cell cycle arrest, and aging-related apoptosis. However, the role of Foxq1 in acute lung injury is unknown. We constructed ex vivo and in vivo acute lung injury models by lipopolysaccharide tracheal perfusion of ICR mice and conditioned medium stimulation of injured MLE-12 cells. Foxq1 expression was increased, and its localization was altered in our acute lung injury model. In normal or injured MLE-12 cells, knockdown of Foxq1 promoted cell survival, and overexpression had the opposite effect. This regulatory effect was likely mediated by Tle1 and the NFκB/Bcl2/Bax signaling pathway. These data suggest a potential link between Foxq1 and acute lung injury, indicating that Foxq1 can be used as a biomarker for the diagnosis of acute lung injury. Targeted inhibition of Foxq1 expression could promote alveolar epithelial cell survival and may provide a strategy for mitigating acute lung injury.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

American journal of respiratory cell and molecular biology - (2024) vom: 04. Apr.

Sprache:

Englisch

Beteiligte Personen:

Zhu, Xi [VerfasserIn]
Hua, Ershi [VerfasserIn]
Tu, Qifeng [VerfasserIn]
Liu, Mei [VerfasserIn]
Xu, Liqin [VerfasserIn]
Feng, Jian [VerfasserIn]

Links:

Volltext

Themen:

Acute lung injury
Alveolar epithelial cell
Foxq1
Inflammatory response
Journal Article
Tle1

Anmerkungen:

Date Revised 04.04.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1165/rcmb.2023-0317OC

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370636619